Citalopram controlled release (Lundbeck A/S/Bausch Health Companies) | Interleukin Related interleukin-related.com

Product Name :
Citalopram controlled release (Lundbeck A/S/Bausch Health Companies)

Search keywords :
Citalopram (hydrobromide)

drugId :
null

Target Vo:
Serotonin transporter

Target Vo Short Name :
SERT

Moa_Name:
Serotonin transporter inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
H. Lundbeck A/S

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Depression

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CDK5 (YP5064) Mouse mAb In Vitro
Vedolizumab supplier
Hsp70 Antibody (YA359): Hsp70 Antibody (YA359) is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Hsp70. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts